A woman in her 50s is reported to have died after suffering a rare blood clot linked to the AstraZeneca COVID-19 vaccine.

The incident is said to have happened in Alberta in Canada.

In a statement on Tuesday, Dr. Deena Hinshaw said the woman died of vaccine-induced immune thrombotic thrombocytopenia (VITT).

The death of the woman is Alberta’s first death linked to the vaccine.

The woman was not identified to protect the “privacy of the grieving family,” Hinshaw said in the statement.

“While any death is tragic, it is important to remember that the risks of dying or suffering other severe outcomes from COVID-19 remain far greater than the risk following AstraZeneca vaccine.”

Hinshaw said the woman was only the second confirmed case of VIIT in the province. More than 253,000 doses of AstraZeneca or CoviSHIELD that have been administered in Alberta.

NewsWire GH can confirm that Ghana has placed a request for millions of the AstraZeneca vaccines and though they are yet to arrive in the country (due to the surge in COVID-19 cases in India) many remain impatient as they eagerly anticipate their arrival and subsequent usage.

Though concerns have been raised about the possible hazards affiliated to the use of the astrazeneca vaccine, Ghana’s government has still opted for them, together with some supplementary numbers from Johnson&Johnson, which have also come under serious scrutiny, also over issues related to blood clots.

The culture of silence – Nana Damoah writes [Opinion]

Previous article

Broadening the tax base should target the new economy – Terkper

Next article

You may also like


Comments are closed.